Background
==========

Approximately 500,000 women are diagnosed with cervical cancer worldwide each year and more than half of them will die from this disease \[[@B1]\]. The highest incidence rates are observed in developing countries where it is the second most prevalent cancer in women and remains a leading cause of cancer related death \[[@B1]\]. Widely implemented screening programs have been responsible for the much lower incidence and mortality rates seen in the developed world. Present day screening methods primarily identify precancer lesions termed cervical intraepithelial neoplasia (CIN). CIN lesions are classified into three subgroups, CIN I, CIN II and CIN III, corresponding to mild, moderate and severe dysplasia/carcinoma *in situ*(CIS), respectively. CIN III lesions have a high likelihood of progression to invasive disease if left untreated \[[@B2]\]. Human Papillomavirus (HPV) has long been established as a necessary but not sufficient cause for cervical carcinoma development. HPV is detected in 99% of invasive disease, 94% of CIN lesions and 46% of normal cervical epithelium \[[@B2]\]. The high risk strains HPV 16 and HPV 18 are most prevalent in invasive disease.

A comprehensive characterization of gene expression of the normal cervical tissue is critical to establish a baseline for comparison against transcriptomes of precancer and cancer. A recent report described the global expression of genes in cervical epithelium using a serial analysis of gene expression (SAGE) based method, enumerating 30,418 sequence tags generated from one normal uterine ectocervical tissue \[[@B3]\]. Another study compared cDNA microarray profiles of cervical tissue to exfoliated cervical cells used in cytology-based cancer screening \[[@B4]\].

In this study, we increased the depth of our understanding of the normal cervical transcriptome and identified gene expression changes in CINIII. We achieved this (i) by using an unbiased Long SAGE (L-SAGE) approach to improve the accuracy of tag-to-gene mapping \[[@B5]-[@B7]\], and (ii) by examining 691,390 L-SAGE tags thus increasing publicly available cervical SAGE data by greater than 20 fold.

Results
=======

In this study, we sequenced 691,390 SAGE tags from four libraries. Cervical L-SAGE libraries N1, N2, C1, and C2 were sequenced to 165,624, 181,224, 173,534, and 171,008 tags, respectively. Duplicate ditags were eliminated from analysis resulting in 136,276, 139,656, 154,828 and 136,386 useful tags respectively and a total of 24, 058 unique tags (Figure [1A](#F1){ref-type="fig"}). 15,438 of the unique tags mapped to annotated UniGene identifiers. The raw data of the sequence tags have been made publicly available (Gene Expression Omnibus, series accession number GSE6252). We characterized the transcriptome of normal cervical tissue and evaluated the highly expressed genes in terms of tissue specificity, concordant expression among the normal libraries and their altered expression in CIN III lesions (Figure [1B](#F1){ref-type="fig"}).

![Flow diagram of SAGE analysis and tag-to-gene mapping. A. Sequence tags yielded from the four SAGE libraries were catagorized. Useful tags indicate all sequenced tags less duplicate ditags. B. The abundance and classification of unique tags in the SAGE libraries of normal cervix tissue (N1, N2) are summarized.](1471-2164-8-142-1){#F1}

Genes Highly Expressed in Normal Cervical Epithelium
----------------------------------------------------

118 unique tags were found to be highly expressed in the normal cervical epithelium (at \>500 tpm in both normal libraries). 103 of these tags mapped to UniGene clusters and represent 100 unique genes and hypothetical proteins (Figure [1](#F1){ref-type="fig"}). Manual examination of tags not mapped by SAGE Genie yielded three additional tags. This results in a total of 107 unique tag-to-gene mappings and 103 unique genes. The abundance of the 118 tags and the genes they represent are summarized in Table [1](#T1){ref-type="table"}.

###### 

Tags expressed in normal cervical libraries at ≥500 tags per million.

  **Gene Symbol**   **N1 tpm**   **N2 tpm**   **C1 tpm**   **C2 tpm**   **SAGE Tag**
  ----------------- ------------ ------------ ------------ ------------ -------------------
  unknown           2510         3623         2655         873          TGATTTCACTTCCACTC
  unknown           2517         3430         3307         1672         CTAAGACTTCACCAGTC
  unknown           594          559          497          594          GTAGGGGTAAAAGGAGG
  unknown           2033         1683         2280         1239         CACCTAATTGGAAGCGC
  unknown           807          852          1298         0            CAAGCATCCCCGTTCCA
  unknown           822          680          814          631          AGGTGGCAAGAAATGGG
  unknown           3757         2714         4134         2757         ACTTTTTCAAAAAAAAA
  unknown           616          687          782          374          ACTAACACCCTTAATTC
  unknown           1519         1525         2222         2126         AAAAAAAAAAAAAAAAA
  unknown           565          780          588          308          TTTAACGGCCGCGGTAC
  unknown           6289         6602         6510         4326         TTCATACACCTATCCCC
  ACTB              2099         1031         1292         1459         GCTTTATTTGTTTTTTT
  ACTG1             1424         1955         1195         1598         CTAGCCTCACGAAACTG
  ANXA1             3713         6480         3701         10162        AGAAAGATGTCTATGTA
  ANXA2             1644         1754         1298         887          CTTCCAGCTAACAGGTC
  AQP3              609          573          930          1136         TTTGCTTTTGTTTTGTT
  ATP5G3            543          773          743          851          GGAATGTACGTTATTTC
  B2M               8718         2821         9443         5712         GTTGTGGTTAATCTGGT
  BZRP              550          960          794          675          GAATTTTATAAGCTGAA
  CCNB1IP1          580          924          988          565          CCACTGCACTCCAGCCT
  CD24              851          559          775          697          GGAACAAACAGATCGAA
  CD74              2348         573          1789         1444         GTTCACATTAGAATAAA
  CEACAM7           793          866          891          594          AATCACAAATAAAAGCC
  CFL1              1937         1031         1744         1679         GAAGCAGGACCAGTAAG
  COX4I1            646          523          969          616          CCTATTTACTGGAAACC
  CSTB              712          3881         1227         2676         ATGAGCTGACCTATTTC
  CTSD              2502         931          2894         1987         GAAATACAGTTGTTGGC
  EEF1A1            2245         1353         1737         1496         TGTGTTGAGAGCTTCTC
  EEF1B2            961          1210         1072         1298         GCATTTAAATAAAAGAT
  EEF1G             726          501          807          418          TGGGCAAAGCCTTCAAT
  FLJ20701          550          501          685          264          ATTTGAGAAGCCTTCGC
  FTH1              2311         1275         2325         5176         TTGGGGTTTCCTTTACC
  GAPD              1666         2363         2312         2816         TACCATCAATAAAGTAC
  GJA1              741          1310         504          513          TGTTCTGGAGAGTGTTC
  GLUL              1658         1275         1905         2845         TACAGTATGTTCAAAGT
  IGHG1             14118        788          349          4715         GAAATAAAGCACCCACC
  IGHG1             18286        773          601          6548         GAAATAAAGCACCCAGC
  ITM2B             1203         1031         1369         865          TAAGTAGCAAACAGGGC
  K-ALPHA-1         1181         795          1783         1239         TGTACCTGTAATATTTT
  KRT13             1380         8206         1815         2046         AAAGCGGGGCTGGAGAA
  KRT15             1152         3494         2713         2427         TAATAAAGAATTACTTT
  KRT5              2216         1539         1892         1371         GCCCCTGCTGACACGAG
  KRT6A             1181         2657         975          1166         AAAGCACAAGTGACTAG
  LAMR1             2987         2370         3268         2911         GAAAAATGGTTGATGGA
  LGALS7            682          2220         446          425          TAAACCTGCTGTGCGGG
  LOC44051          719          702          588          719          GGGTTGGCTTGAAACCA
  LY6D              1424         2248         1796         3072         GAGATAAATGATTTAAA
  MGC71999          998          1353         924          565          TCACAAGCAAATGTGTC
  MYL6              1115         559          995          1063         GTGCTGAATGGCTGAGG
  NET-5             1783         780          1298         997          CACAAACGGTAGTTTTG
  PERP              1306         2828         1828         2236         CCACAGGAGAATTCGGG
  PLCB4             866          752          1072         733          AAAACATTCTCCTCCGC
  PPIA              1504         1697         1951         1452         CCTAGCTGGATTGCAGA
  PTMA              1049         1017         1518         697          TTCATTATAATCTCAAA
  RPL10             2223         1797         1944         1283         AGGGCTTCCAATGTGCT
  RPL10A            998          652          1414         821          GGCAAGCCCCAGCGCCT
  RPL11             1130         773          1124         829          CGCTGGTTCCAGCAGAA
  RPL12             932          580          865          726          ACATCATCGATGACATC
  RPL13A            2818         1998         2855         2383         AGGCTACGGAAACAGGC
  RPL13A            1490         716          1434         1195         CTCCTCACCTGTATTTT
  RPL21             2091         1353         1899         1554         GCATAATAGGTGTTAAA
  RPL23             1196         1031         1072         1114         ATTCTCCAGTATATTTG
  RPL27A            1923         1310         1989         1899         GAGGGAGTTTCATTAAA
  RPL28             1996         1504         1983         1833         GCAGCCATCCGCAGGGC
  RPL29             1049         773          1104         814          GGGCTGGGGTCCTCCTG
  RPL3              917          702          840          983          GGACCACTGAAGAAAGA
  RPL30             1541         1017         1259         961          CCAGAACAGACTGGTGA
  RPL31             609          573          568          491          AAGGAGATGGGAACTCC
  RPL32             1512         1024         1550         1371         TGCACGTTTTCTGTTTA
  RPL35             638          551          665          572          CGCCGCCGGCTCAACAA
  RPL36             1570         1275         1628         1173         AGGAAAGCTGCTGCCAA
  RPL37             5063         3272         6362         6064         CAATAAATGTTCTGGTT
  RPL37A            1350         938          1259         953          AAGACAGTGGCTGGCGG
  RPL4              521          537          465          359          CGCCGGAACACCATTCT
  RPL41             2649         1812         2609         1906         TTGGTCCTCTGCCCTGG
  RPL7              1702         1160         1427         1180         ATTATTTTTCTAAGCTG
  RPLP0             815          1239         846          601          CTCAACATCTCCCCCTT
  RPLP1             3574         2735         3507         2398         TTCAATAAAAAGCTGAA
  RPLP2             2422         1461         2196         2376         GGATTTGGCCTTTTTGA
  RPS11             1365         802          917          770          TCTGTACACCTGTCCCC
  RPS12             690          695          601          396          GCCGAGGAAGGCATTGC
  RPS14             1159         859          1240         843          TAAAAAAAAAAAAAAAA
  RPS18             1071         1053         1085         858          TGGTGTTGAGGAAAGCA
  RPS19             2598         1604         2357         2618         CTGGGTTAATAAATTGC
  RPS20             903          695          1020         667          GCTTTTAAGGATACCGG
  RPS23             961          637          833          704          CTGTTGGTGATATTCCT
  RPS25             1042         988          924          660          AATAGGTCCAACCAGCT
  RPS26             2576         1002         1938         873          TAAGGAGCTGAGTTCTT
  RPS27A            815          623          988          887          AACTAAAAAAAAAAAAA
  RPS28             998          902          1053         1034         GACGACACGAGCCGATC
  RPS29             2245         1940         2325         2317         ATAATTCTTTGTATATA
  RPS3A             1218         823          1427         1232         GTGAAGGCAGTAGTTCT
  RPS4X             1541         952          1615         924          TCAGATCTTTGTACGTA
  RPS8              4021         3587         4282         3996         TAATAAAGGTGTTTATT
  RPS9              587          530          407          521          CCAGTGGCCCGGAGCTG
  S100A10           514          501          543          506          AGCAGATCAGGACACTT
  S100A2            2950         723          2235         3505         GATCTCTTGGGCCCAGG
  S100A7            2899         752          388          5990         GAGCAGCGCCCTGTTCC
  S100A8            690          1031         827          1466         GCTTTTTTTGTGGGCTG
  S100A8            11880        25205        8855         24629        TACCTGCAGAATAATAA
  S100A9            13561        17078        10089        18660        GTGGCCACGGCCACAGC
  SERPINB3          1137         1454         704          917          CCTTTCTCTCTTTCTCT
  SFN               1255         1976         1505         1569         TTTCCTCTCAATAAAGT
  SMAD2             2935         2341         3378         1987         CCCATCGTCCTAGAATT
  SPINK5            712          4189         0            1305         TCCACCAAGTCTGAGCC
  SPRR3             1600         11757        3888         5968         TTTCCTGCTCTGCCCTC
  SPRR3             1636         13068        4121         8329         TTTCCTGCTCTTCCCTC
  STX3A             646          1905         1318         1312         TAAAATGTTTATGATAA
  SUI1              1446         1239         1259         2009         CAATAAACTGAAAAGAG
  TAGLN2            660          616          769          543          GTCTGGGGCTTGAGGAA
  TMSB4X            2245         616          1175         917          TTGGTGAAGGAAGAAGT
  TPI1              947          1382         1589         1584         TGAGGGAATAAACCTGG
  TPT1              4726         3659         4915         4568         TAGGTTGTCTAAAAATA
  TXNL5             660          838          258          924          TTAGCAATAAATGATGT
  UQCRH             646          508          930          726          GGTTTGGCTTAGGCTGG
  VAMP8             521          795          459          491          TGGCTGGGAAACTGTTG
  VPS13B            763          594          911          0            CACTACTCACCAGACGC
  YWHAZ             587          702          517          814          TAAGTGGAATAAAAGTT

To determine cervical tissue specific expression, we first investigated the expression of the 107 genes using expression data available at the National Center for Biotechnology Information (NCBI) Unigene database and the National Cancer Institute (NCI) Cancer Genome Anatomy Project (CGAP) SAGE Anatomical Viewer. Based on CGAP information, only four of the 107 genes were unique to cervical tissue: *carcinoembryonic antigen-related cell adhesion molecule 7*(*CEACAM7*), *keratin 6A*(*KRT6A*), *small proline-rich protein 3*(*SPRR3*) and *S100 calcium binding protein A7*(*S100A7*). These genes were further investigated for expression by RT-PCR in 20 different tissue types and three normal cervical specimens (Figure [2](#F2){ref-type="fig"}). *CEACAM7*was found to be expressed in colon, larynx, pancreas and two of the three normal cervical specimens. *KRT6A*expression was detected in placenta, thymus, tongue, prostate, larynx, colon, skin and in all three of the normal cervical specimens. *SPRR3*was found strongly expressed in placenta, thymus, colon, tongue, larynx and all three of the normal cervical cases. *S100A7*showed expression in placenta, thymus, and tongue and in all three of the normal cervical specimens. All four genes were prominently expressed in the cervical epithelium but this combination of genes was not expressed in the tissues examined (Figure [2](#F2){ref-type="fig"}).

![Validation of tissue specificity of gene expression. Reverse transcriptase PCR of four genes in 20 tissue types and three normal cervical specimens. Heart (Ht), breast (Br), placenta (Pl), lung (Lg), liver (Lv), skeletal muscle (Sk), kidney (Kd), pancreas (Pn), spleen (Sp), thymus (Ty), prostate (Pr), testis (Ts), ovary (Ov), small intestine (Sm), colon (Co), peripheral leukocytes (Lk), tongue (Tg) larynx (Lx), stomach (St), skin (Sn). Ca, Cb and Cc are three individual normal cervical tissue specimens.](1471-2164-8-142-2){#F2}

Disrupted Gene Expression in CIN III
------------------------------------

All tags were assessed for altered expression in CIN III. Four hundred and seventy-six tag show greater than two fold increase in CIN III and are expressed at greater than 15 tpm (see Additional file [1](#S1){ref-type="supplementary-material"}) while 315 tags were decreased in CIN III (see Additional file [2](#S2){ref-type="supplementary-material"}).

We determined if the expression of the 107 unique tags, that were highly expressed in normal cervical libraries (\> 500 TPM), were disrupted in CIN III. Comparison of expression levels in N1, N2 to the CIN III libraries using the Z-test revealed five differentially expressed genes (Table [2](#T2){ref-type="table"}). *Annexin 2*(*ANXA2*), *galectin 7*(*LGALS7*) and *connexin 43*(*GJA1*) exhibited decreased expression in CIN III (Z \< -1.96) while *aquaporin 3*(*AQP3*) and *ribosomal-like protein 37*(*RPL37*) increased in expression (Z \> 1.96). Real-time PCR was performed on a panel of 6 new cervical specimens, three each of normal and CIN III for all five of these genes (Figure [3](#F3){ref-type="fig"}). Expression results were normalized to housekeeping gene *ACTB and 18S*(Figure [3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}, respectively). Decrease in expression of *ANXA2*, *LGALS7*and *GJA1*in CIN III was confirmed while increase in expression of AQP3 and RPL37 were not.

###### 

Highly expressed genes with altered expression in CIN III.

                                                  **Z_Score**^a^                         
  ------------------- ------ ------ ------ ------ ---------------- ------ ------- ------ --------
  TTTGCTTTTGTTTTGTT                               -4.7             -3.1   -5.1    -3.5   AQP3
  CAATAAATGTTCTGGTT   5063   3272   6362   6064   -3.5             -4.6   -10.8   -12    RPL37
  TGTTCTGGAGAGTGTTC   741    1310   504    513    2.4              2.6    6.9     7.3    GJA1
  TAAACCTGCTGTGCGGG   682    2220   446    425    2.9              2.7    12.9    13.4   LGALS7
  CTTCCAGCTAACAGGTC   1644   1754   1298   887    5.6              2.4    6.3     3.2    ANXA2

^a^Z \> 1.96; reduced expression in CIN III, Z \< -1.96; increased expression in CIN III.

![Summary of test panel quantitative PCR results of genes with altered expression in CIN III L-SAGE libraries. A panel of three new CIN III cases (CIN III A, CIN III B, CIN III C) were investigated for expression and compared to three new normal specimens. Gene expression was normalized to *ACTB*and 18S (Figure 3A and 3B, respectively). Zero on the Y-axis denotes mean expression levels of the respective genes in normal cervical tissue. All five genes investigated showed decreased expression.](1471-2164-8-142-3){#F3}

Viral (HPV 16) tags in L-SAGE libraries
---------------------------------------

HPV transcripts were also detected by L-SAGE. Tags from all four libraries were mapped against the genomes of HPV 16 and HPV 18. While no tags mapped to HPV 18, twelve tags from the CIN III libraries mapped to the more prevalent HPV 16 genome (Table [3](#T3){ref-type="table"}). The highest transcript counts of known genes belonged to E5 at 1,180 and 290 tpm and E2 at 240 and 20 tpm, in libraries C2 and C1, respectively. Compared by BLAST \[[@B8]\] against the RefSeq Genome collection, none of the twelve tags matched 100% to the human genome. All twelve tags were also mapped against human transcript sets (mitochondrial genome, RefSeq, UCSC gene set, Unigene, Ensembl, UCSC mRNA, UCSC EST, SAGEmap and SAGEgenie SAGE tag sets). No tags matched to any of the described transcript sets with the exception of CATGCACGCTTTTTAATTACA and CATGTGTATGTATTAAAAATA which mapped to human EST BF909200. The full length EST sequence is 97% identical with the HPV 16 *E5*gene and was likely amplified from HPV sequences in the originating uterine tumour lesion.

###### 

Tags mapping to HPV16 genome.

  Tag                     Strand   Gene    N1 tpm   N2 tpm   C1 tpm   C2 tpm
  ----------------------- -------- ------- -------- -------- -------- --------
  CATGCACGCTTTTTAATTACA   \+       E5      0        0        290      1,180
  CATGCAACATAAATAAACTTA   \+       \-      0        0        6        770
  CATGGCATTGGACAGGACATA   \+       E2      0        0        6        240
  CATGTGTATGTATTAAAAATA   \-       E5      0        0        6        155
  CATGACACAATAGTTACACAA   \+       \-      0        0        6        125
  CATGGGGAGGAATATGATTTA   \+       L1/L2   0        0        0        30
  CATGTAGACGACACTGCAGTA   \-       E2      0        0        0        20
  CATGGTAGATTATGGTTTCTG   \-       E7      0        0        6        7
  CATGTCGTAGGTACTCCTTAA   \-       L1/L2   0        0        0        7
  CATGGGGATCCTTTGCCCCAG   \-       L1/L2   0        0        0        7
  CATGATAATATATGTTTGTGC   \-       L1/L2   0        0        0        7
  CATGCGCCTAGAATGTGCTAT   \+       E2      0        0        0        0

Discussion
==========

This study represents the most comprehensive gene expression analysis of cervical tissue reported to date. In total, 691,390 L-SAGE tags were sequenced (Figure [1A](#F1){ref-type="fig"}). The length of the L-SAGE tags (21 bp as compared to 14 bp in conventional SAGE) greatly reduces tag-to-gene mapping ambiguity \[[@B6]\]. 107 of the 118 (88%) highly expressed tags (i.e. \>500 tpm) were mapped to known genes or hypothetical proteins encompassing 103 unique genes (Figure [1B](#F1){ref-type="fig"}).

Assessing Highly Expressed Tags by Functional Group
---------------------------------------------------

Of the 107 highly expressed tags (\>500 tpm), 47 were expressed at extremely high levels (\>10^3^tpm) including genes frequently used as controls in expression analysis, *GAPDH*and *ACTB*. High expression of 20 genes in normal cervical tissue was reported in a previous study \[[@B3]\]. Fifteen of these genes are encompassed by our list of 107 high expressers. The most highly expressed tags expressed at \>10^4^tpm (GTGGCCACGGCCACAGC and TACCTGCAGAATAATAA) mapped to the genes *S100A9*and *S100A8*, respectively. Both genes belong to the calcium binding protein family. These findings are in agreement with a previous report of high *S100A8*and *S100A9*levels in cervical tissue \[[@B3]\]. Although the function of these genes is not well understood, genes within this family have been proposed to participate in a variety of cellular process including cell cycle, wound healing and cell differentiation \[[@B9]\].

Assigning the 103 highly expressed genes to one of eleven broad functional groups allowed for an assessment of those cellular processes represented by the most abundant transcripts. These cellular processes include calcium binding proteins, cell cycle or cell death, cytoskeleton, immune functioning, keratinization, membrane proteins, mitochondrial, protein processing, translation (ribosomal proteins), translation (non ribosomal proteins) with a small fraction of tags mapping to other functional groups or to genes with no known function (Figure [4A](#F4){ref-type="fig"}). The 41 ribosomal genes account for the greatest proportion of highly expressed genes at 28% and 31% (normal and CIN III, respectively). In contrast, only five calcium binding genes account for the second largest functional subgroup of highly expressed tags, 18% and 19% (normal and CIN III, respectively).

![Functional groupings of tags highly expressed (\>500 tpm) in normal libraries. Categories are as described. The Other group consists of tags which map to known genes but are not encompassed by any of the ten categories. The Unknown function group consists of tags mapping to no known genes. **A)**Tag counts in the normal libraries are categorized by functional group. **B)**Tags found in A were quantified in both CIN III libraries and categorized according to the same functional grouping scheme. In both groups Ribosomal genes accounted for the greatest number of tags while only the keratins changed in expression or were decreased in the CIN III libraries.](1471-2164-8-142-4){#F4}

The relative expression levels of the functional groups do not change greatly between the normal and CIN III libraries however the keratin and immune related functional groups show slight decrease from 12% and 17% in CIN III to 9% and 14% in normal tissue (keratin and immune groups, respectively).

All tags expressed at or greater than 15 tpm in Normal and CIN III libraries (2,814 and 3,279 respectively) were also evaluated according functional group using Onto-Express (see Additional File [3](#S3){ref-type="supplementary-material"}) \[[@B10]\]. The most represented groups included DNA dependent transcription regulators and transcription in both the Normal and CIN III libraries.

Cervical Tissue Gene Signature
------------------------------

Four of the 103 unique genes we found to be abundantly expressed in normal cervical tissue were documented to have limited or no expression in other tissues according to the web resources NCBI UniGene \[[@B11]\] and NCI CGAP SAGE Anatomical Viewer \[[@B12],[@B13]\] (Figure [1B](#F1){ref-type="fig"}). These genes (*CEACAM7*, *SPRR3*, *S100A7*and *KRT6A*) are our candidates for an expression signature unique to normal cervical tissue and were further investigated in a panel of 20 different tissue types and three new normal cervical specimens. We found that all four of these genes were not abundantly expressed simultaneously in any of the 20 tissues examined (Figure [2](#F2){ref-type="fig"}). Placenta, thymus and tongue were found to express a combination of three genes (*S100A7*, *SPRR3*and *KRT6A*), while colon expressed another combination (*CEACAM7*, *SPRR3*and *KRT6A*). *KRT6A*and *SPRR3*expression was observed in larynx tissue with only minimal expression detected for *S100A7*and *CEACAM7*. In contrast, two of the cervical cases strongly expressed all four genes investigated while only the third showed very low *CEACAM7*expression. Significantly, our study is the first to document *CEACAM7*expression in cervix. The data suggest that abundant expression of *CEACAM7 and S100A7*collectively, are unique to cervical tissue and have the potential to serve as useful biomarkers in identifying origins of metastatic disease.

It is interesting to note that decreased expression of three of the genes is linked to abnormal growth and organization of epithelium. For example, *CEACAM7*is a member of the carcinoembryonic antigen family of genes and expression has been documented in highly differentiated normal colon epithelium and the apical surface of normal ductal pancreas epithelium, while loss of expression has been reported in colon hyperplastic polyps \[[@B14]\]. Another member of this gene family, CEACAM1, is shown to have no or very low expression in cervical carcinoma \[[@B15]\]. Decreased expression of *KRT6A*and *S100A7*have been associated with breast, lung and ovarian cancer \[[@B16]-[@B20]\]. *SPRR3*belongs to the class of small proline rich genes which are expressed in differentiated keratinocytes and has previously been shown to be highly expressed in normal cervical tissue \[[@B21]\].

Genes Altered in Expression in CIN III
--------------------------------------

The 107 highly expressed unique tags in the normal libraries were assessed for expression changes in CIN III. Two genes showed increased expression (*AQP3*and *RPL37*) while three genes declined in transcript counts in the CIN III libraries (*ANXA2*, *GJA1*and *LGALS7*). All five were evaluated by real-time PCR in a new cervical tissue panel. Results for *ANXA2*, *LGALS7*and *GJA1*confirmed L-SAGE findings.

Panel results for *GJA1*are in agreement with those reported by King *et al.*in that *GJA1*expression was detected in normal cervical epithelium while reduced expression was observed in CIN III lesions investigated \[[@B22]\]. It has been suggested that this pattern may be a consequence of epithelial disorganization and not causative in dysplasia development \[[@B23],[@B24]\].

The high expression of *LGALS7*in normal cervical epithelium contrasted by the low expression seen in the CIN III lesions in the tissue panel we report here is similar to those expression patterns seen in studies of other normal tissue types compared to their respective carcinomas including cornea and larynx \[[@B25]\]. *LGALS7*expression has been hypothesized in all stratified epithelium tissue types and has been experimentally detected in human cornea, heart, larynx, tongue, skin, thymus and thyroid \[[@B26]-[@B28]\]. Though, *LGALS7*has been investigated in the context of cell line models, it is interesting to note that expression of this gene in cervical epithelium has not been previously reported \[[@B26]-[@B28]\]. *LGALS7*is one of fifteen members of the B-galactoside-binding lectin family, some of which have been shown to influence cell growth, cell cycle, apoptosis and cell migration via their predicted role in homeostasis, however, the role of *LGALS7*in cancer is unclear \[[@B27],[@B29]\]. Support for the pro-apoptotic function of *LGALS7*was reported by Kuwabara *et al.*and Bernard *et al.*who identified cells more sensitive to apoptosis when *LGALS7*expression was high in the epithelium derived cells \[[@B28],[@B30],[@B31]\]. In contrast, Demers *et al.*showed an increase in *LGALS7*expression in lymphoma cells and suggested a positive role in cell growth and dispersal through induced matrix metalloproteinase 9 (*MMP9*) expression \[[@B32]\]. We did not observe a statistically significant change in *MMP9*in the four libraries investigated. This variance in expression suggests multiple roles for *LGALS7*that may be tissue-type dependent.

The third gene investigated, *ANXA2*, is known to be highly expressed in epithelial cells and is localized to the plasma membrane and endosome. It has been suggested to function in linking membrane to membrane and membrane to cytoskeleton \[[@B33]\]. The decrease in expression we observe suggests that the loss of *ANXA2*may be a causative factor in disorganisation of the epithelial architecture, which is characteristic of cervical neoplastic lesions. ANXA2 is also known to bind with S100A10 and participates in transport channel function across the plasma membrane \[[@B33]\]. Interestingly, the ANXA2 binding site on S100A10 also binds NS3, a viral protein from the bluetongue virus, and therefore directly competes with ANXA2. The S100A10 protein has also been shown inhibit Hepatitis B virus polymerase (HBV pol) activity \[[@B34]\]. It is plausible that a S100A10-ANXA2 complex may have a role in HPV infection or viral lifecycle. *S100A10*expression was high and consistent in Normal and CIN III libraries whereas *ANXA2*decreased in the CIN III libraries.

The above real-time PCR results were normalized to the widely accepted housekeeping gene *ACTB*(Figure [3A](#F3){ref-type="fig"}). For comparison we also normalized the genes to a second housekeeping gene 18S (Figure [3B](#F3){ref-type="fig"}). Briefly, results for *GJA1*and *LGALS7*were in agreement to those when normalizing to *ACTB*, however *ANXA2*was shown to be increased in CIN III as expected by the SAGE data. but this does not concur with the QPCR results when normalized to ACTB. One possible explanation is that on average, the ACTB cycle threshold was \>1.3 Ct lower in the CIN III cases indicating an increase in ACTB expression in CIN III lesions. Any Ct decrease less than this in the genes investigated would appear as a decrease in gene expression in CIN III when normalized to ACTB but and increase when normalized to 18S.

The real-time PCR results for *AQP3*and *RPL37*did not concur with L-SAGE data and may be due to interindividual differences rather than a representation of changes present in CIN lesions or cancer. It is interesting to note that *RPL37*overexpression in prostate cancer, colon cancer cell lines and clinical specimens have been reported \[[@B35],[@B36]\]. Our L-SAGE results also suggest a similar pattern in cervical neoplasia. Results for these genes when normalized to 18S showed an increase in expression in only CIN III A (see Additional file [3](#S3){ref-type="supplementary-material"}).

Wong *et al*investigated gene expression in invasive cervical carcinoma by DNA microarray \[[@B37]\]. We investigated this publicly available data through NCBI GEO \[[@B38]\]. Briefly, in this data, GJA1 showed a small decrease in expression in invasive disease while LGALS7 was detected in only four of the 26 specimens, three of which were normal tissue. Moderate AQP3 expression was detected in the majority of cases including the control group. Expression of ANXA2 and RPL37 was not assessed in the microarray study.

Human L-SAGE Tags Map to the HPV Genome
---------------------------------------

HPV is an established etiological factor in cervical cancer \[[@B2]\]. There are over 100 known strains of HPV, however HPV 16 and HPV 18 are considered to be the frequent high risk types owing to higher rates of persistent infection, higher rates of progression to cervical neoplasia, and shorter median progression times than other HPV strains \[[@B2]\]. HPV 16 is the most common strain and can be detected in approximately 60% of cervical cancers, while HPV 18 infection occurs in approximately 10--20%. Uncontrolled expression of *E6*and *E7*genes from strains 16 or 18 are considered to be essential for oncogenic transformation and function through inhibition of host cell tumour suppressors p53 and the retinoblastoma protein (Rb) \[[@B2]\].

This is the first study to mine human SAGE libraries for viral transcripts. Overall, CIN III library C2 (2,548 tpm) possessed a greater number of tag counts from the more prevalent HPV 16 strain when compared to C1 (320 tpm) (Table [3](#T3){ref-type="table"}). HPV 18 tags were not found in any library and no viral tags were detected in the normal libraries. With the exception of two tags, the viral tags expressed in cervical SAGE did not map to known human genes or expressed sequences. The exceptions, CATGCACGCTTTTTAATTACA and CATGTGTATGTATTAAAAATA, mapped to a single human EST isolated from a uterine tumour (EST BF909200). The full length EST sequence is 97% identical with the HPV 16 genome, more specifically the *E5*gene, and therefore was likely amplified from HPV sequences in the original lesion.

Tags mapping to the *E5*gene accounted for the greatest proportion of HPV tags mapping to known transcripts in both C1 and C2 (93% and 52%, respectively). *E5*is considered to be one of three HPV 16 oncogenes (*E5*, *E6*and *E7*) and is highly expressed in basal cells of premalignant cervical lesions \[[@B39]\]. This expression declines as cells differentiate and move toward the apical face of the epithelium whereas *E6*and *E7*expression increases \[[@B39]\]. *E5*is detected throughout all epithelium layers in high grade lesions such as CIN III. In contrast, expression is restricted to layers closest to the basal cells in low grade lesions, implying that *E5*expression may be limited to undifferentiated basal cells \[[@B40],[@B41]\]. The high expression of *E5*we observe in the CIN III libraries and the absence of HPV 16 genes in the normal libraries is in concordance with such studies.

An increase in sample size and inclusion of mild and moderate stages of cervical intraepithelial neoplasia will aid in quantifying the relationship between viral gene expression and disease. This will also assist in further elucidating genes important in early lesion transcriptome events. A comparison of such events with those seen in later stages will help to identify genes important in the molecular pathogenesis of the disease.

Conclusion
==========

In this study we have described the transcriptome of normal cervical tissues and compared against that of CIN III lesions. This was achieved by construction of four L-SAGE libraries and sequencing to the depth of 172,848 tags per library on average. We highlighted that the Long-SAGE technique provides a comprehensive profile of the transcriptome without focusing on only known genes. Potent tumour suppressors (e.g. *PTEN*), cell cycle mediators (e.g. *CCND1*), and cellular respiration genes (e.g. *NDUFA1*) were found to be tightly regulated in the normal libraries. An expression signature of four highly expressed genes (*KRT6A*, *CEACAM7*, *S100A7*and *SPRR3*) in normal cervical epithelium was identified and confirmed, and three abundantly expressed genes (*ANXA2*, *GJA1*and *LGALS7*) were found to have altered expression in CIN III. Furthermore, this is the first study to have identified viral tags in human SAGE libraries demonstrating the versatile nature of SAGE data, which allows for mining and re-mining according to newly posed questions. HPV 16 *E5*transcripts were found most highly expressed while few *E7*and no *E6*transcripts were enumerated.

The identification of expression changes associated with stages of disease progression will help further our understanding of cervical cancer development and potentially elucidate novel targets for diagnosis and treatment. Establishing a baseline from which to compare is essential to the identification of such aberrations and the 20 fold increase in cervical gene expression data presented here is a significant contribution to this effort.

Methods
=======

Sample selection
----------------

The specimens were collected immediately prior to the LEEP (Loop electrosurgical excision procedure) cone biopsy targeting a small portion of the affected epithelium. These specimens were collected with patient consent at the Vancouver General Hospital Women\'s Clinic at Vancouver Hospital & Health Science Centre. Cases were assessed by cervical cancer pathologists at Vancouver Hospital and Health Science Centre and were selected without prior knowledge of HPV status. Specimens N1 and N2 in this study were observed to be normal squamous epithelia whereas C1 and C2 were identified as high grade dysplasia or CIN III. Detailed information on specimen pathology based on the LEEP cone specimens can be found in Additional file [4](#S4){ref-type="supplementary-material"}. All samples were stored immediately in RNA *later*and stored at -80°C. Three cases each of CIN III (CIN III A, CIN III B and CIN III C) and normal cervical tissue (NA, NB and NC) which were used for target validation through real-time PCR were also collected, assessed and stored in the same manner.

L-SAGE Library Construction and Sequence Tag Analysis
-----------------------------------------------------

The biopsies were individually homogenised in Lysis Binding buffer (100 mM Tris-HCl, pH7.5, 500 mM LiCl, 10 mM EDTA, pH 8.0, 1% LiDS, 5 mM dithiothreitol). Long SAGE libraries were constructed according to the L-SAGE kit manual (Invitrogen, Ontario, Canada). Sequencing was performed at the BC Cancer Agency Michael Smith Genome Sciences Centre. L-SAGE employs 21 basepair sequence tags, reducing the ambiguity in tag-to-gene mapping that is sometimes encountered in classic SAGE libraries which use 14 basepair sequence tags.

Data Analysis
-------------

Tags were mapped using the February 12, 2006 version of *SAGE Genie*\[[@B13]\], and raw tag counts excluding duplicate ditags were normalized to tags per million (tpm). A Z-test analysis, standard for SAGE data analysis, was performed as previously established by Kal *et al.*for comparison of one SAGE library to another using an established cut-off of 1.96 on the absolute Z-score to determine statistically significant differences in expression levels between normal and CIN III \[[@B42]\].

Reverse Transcriptase PCR
-------------------------

For validation of cervical tissue gene signature, human Multiple Tissue cDNA Panel I and II (Clontech, Mississauga, Ontario) and total RNA for human larynx, skin, stomach and tongue (Stratagene, Cedar Creek, Texas) were used. Five-hundred nanograms from larynx, skin, stomach and tongue was used to generate cDNA. Final concentrations of PCR reagents for cervical tissue signature were 0.5 μM primer, 2 mM MgCl~2~, 0.2 mM dNTP, 1× PCR buffer (Invitrogen), 0.5 U Taq polymerase and 1 μL of cDNA (annealing temperatures: 55°C (*ACTB*, *CEACAM7*), 60°C (*KRT6A*), 65°C (*SPRR3*and *S100A7*). Total RNA for the panel of six cervical specimens used for validation of genes was isolated using Trizol (Invitrogen) and cDNA was generated using the High Capacity TaqMan Reverse Transcription Reagents, according to the manufacturer\'s instructions (Applied Biosystems, Foster City, CA).

Expression of genes selected by data analysis were analyzed by real-time PCR using TaqMan^®^Gene Expression Assays on the ABI 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA), according to manufacturer\'s instructions. Samples were run in duplicate and normalized against an *beta-actin*(*ACTB*) endogenous control (HuACTB, Applied Biosytems). Assay IDs include *AQP3*, Hs00185020_m1; *GAL7*, Hs00170104_m1; *RPL37*, Hs02340038_g1; and *GJA-1*, Hs00748445_s1. The relative quantification of these target genes in CIN III (CIN III A, CIN III B and CIN III C) samples compared to normal tissue (NA, NB and NC) samples was performed using the established 2^-ΔΔCt^method, (Applied Biosystems, *Relative Quantitation Of Gene Expression, ABI PRISM 7700 Sequence Detection System: User Bulletin \#2*). The cycle threshold (Ct) value of the target gene was normalized to *ACTB*by subtracting the Ct value for *ACTB*from that of the target gene (ΔCt gene = Ct gene - Ct *ACTB*). This number was then averaged from the three normal cases (ave ΔCt normal). The mean fold change of each gene between normal and CIN III was calculated using the following equation: 2 ^-(ΔCt\ gene\ -\ ave\ ΔCt\ normal)^. The relative quantification values were then plotted, one indicating no change with respect to normal cervical tissue.

HPV Tag-to-Gene Mapping
-----------------------

Viral genomic sequence files (viral1.genomic.fna and HPV11.txt) were downloaded from public repositories and processed into 21 bp SAGE tags at every *Nla III*site in both orientations using custom Perl scripts \[[@B43],[@B44]\].
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